Mon Dec 23 20:07:27 UTC 2024: ## Senores Pharmaceuticals IPO Sees Strong Grey Market Premium
**MUMBAI, INDIA** – Senores Pharmaceuticals’ Initial Public Offering (IPO) is generating significant buzz, with its grey market premium (GMP) exceeding Rs 200. The company successfully raised Rs 260.63 crore from anchor investors ahead of the IPO launch. This strong pre-IPO interest indicates high investor anticipation for the listing. The news comes amidst other IPO activity, including the Newmalayam Steel IPO and Carraro India IPO, both of which are also attracting market attention. While other market news focuses on IT stocks, demergers of major companies like ITC and Vedanta, and overall market volatility, the Senores Pharmaceuticals IPO is capturing headlines due to its robust grey market performance.
First Piper 